Frontiers | Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
Biomarkers in drug discovery and development
Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Cabozantinib Slows Progression of Rare Kidney Cancer - NCI
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research
Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors - eBioMedicine
Synthetic biomarkers: a twenty-first century path to early cancer detection | Nature Reviews Cancer
Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer - Johns Hopkins Medicine
Kidney Cancer: Recent Advances and Future Directions | Journal of Clinical Oncology
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Exosomes as a Multicomponent Biomarker Platform in Cancer: Trends in Cancer
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
Prognostic and predictive biomarkers in Renal Cell Carcinoma. | Download Table
An Immune Atlas of Clear Cell Renal Cell Carcinoma - ScienceDirect
The immunology of renal cell carcinoma | Nature Reviews Nephrology
Frontiers | Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
